|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186,800.00 KRW | +0.05% |
|
+1.91% | +3.61% |
| 12-11 | Celltrion USA, Inc. announced that it expects to receive $532.1 million in funding from Celltrion, Inc. | CI |
| 12-10 | Celltrion, Inc. announces Annual dividend | CI |
Company Valuation: Celltrion, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 48,989,351 | 27,592,583 | 23,000,359 | 27,970,378 | 40,365,453 | 40,871,307 | - | - |
| Change | - | -43.68% | -16.64% | 21.61% | 44.32% | 1.25% | - | - |
| Enterprise Value (EV) 1 | 49,090 | 27,117 | 23,236 | 29,280 | 41,531 | 41,884 | 41,792 | 40,580 |
| Change | - | -44.76% | -14.31% | 26.01% | 41.84% | 0.85% | -0.22% | -2.9% |
| P/E ratio | 94.4x | 47.2x | 41.6x | 53.7x | 91.7x | 52.5x | 34.7x | 28.5x |
| PBR | 14.4x | 6.87x | 5.34x | 2.46x | 2.2x | 2.32x | 2.2x | 2.06x |
| PEG | - | 3.8x | -9.54x | -20.3x | -2.1x | 0.6x | 0.7x | 1.3x |
| Capitalization / Revenue | 26.5x | 14.6x | 10.1x | 12.9x | 11.3x | 9.87x | 8.28x | 7.2x |
| EV / Revenue | 26.5x | 14.3x | 10.2x | 13.5x | 11.7x | 10.1x | 8.47x | 7.15x |
| EV / EBITDA | 55.1x | 27.9x | 26.6x | 32.6x | 45.6x | 28.6x | 21.7x | 18x |
| EV / EBIT | 68.9x | 36x | 35.9x | 44.9x | 84.4x | 37.2x | 26.6x | 21.3x |
| EV / FCF | 186x | 46x | -211x | 89.5x | 54.2x | 56.4x | 39.9x | 34.5x |
| FCF Yield | 0.54% | 2.17% | -0.47% | 1.12% | 1.85% | 1.77% | 2.5% | 2.9% |
| Dividend per Share 3 | - | 660.4 | - | 457.9 | 721.2 | 739.4 | 792.2 | 868.8 |
| Rate of return | - | 0.38% | - | 0.25% | 0.4% | 0.4% | 0.42% | 0.47% |
| EPS 3 | 3,284 | 3,691 | 3,530 | 3,437 | 1,966 | 3,560 | 5,387 | 6,548 |
| Distribution rate | - | 17.9% | - | 13.3% | 36.7% | 20.8% | 14.7% | 13.3% |
| Net sales 1 | 1,849 | 1,891 | 2,284 | 2,176 | 3,557 | 4,140 | 4,933 | 5,679 |
| EBITDA 1 | 891.4 | 972.1 | 873.6 | 897.2 | 910.3 | 1,463 | 1,927 | 2,255 |
| EBIT 1 | 712.1 | 753.9 | 647.2 | 651.5 | 492 | 1,126 | 1,572 | 1,904 |
| Net income 1 | 511.3 | 575.1 | 533.2 | 535.6 | 422.7 | 816.8 | 1,229 | 1,485 |
| Net Debt 1 | 100.4 | -475.5 | 235.5 | 1,310 | 1,165 | 1,013 | 921 | -291.1 |
| Reference price 3 | 309,911.93 | 174,344.89 | 146,978.02 | 184,523.81 | 180,288.46 | 186,800.00 | 186,800.00 | 186,800.00 |
| Nbr of stocks (in thousands) | 158,075 | 158,264 | 156,488 | 151,581 | 223,894 | 218,797 | - | - |
| Announcement Date | 22/02/21 | 16/02/22 | 03/03/23 | 29/02/24 | 25/02/25 | - | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 52.47x | 10.12x | 28.62x | 0.4% | 27.66B | |
| 36.03x | 5.24x | 17.55x | 0.96% | 45.43B | |
| 31.29x | 3.16x | 13.65x | -.--% | 37.85B | |
| 102.5x | 6.24x | 62.58x | -.--% | 35.31B | |
| 37.69x | 6.1x | 27.7x | -.--% | 15.72B | |
| -14.13x | 5514.01x | -13.31x | -.--% | 15.26B | |
| 28.89x | 2.14x | 10.93x | -.--% | 14.25B | |
| -47.51x | 10.27x | 26431.56x | -.--% | 12.56B | |
| -56.36x | 15.84x | -129.84x | -.--% | 13.47B | |
| -35.89x | 13.59x | -38.79x | -.--% | 13.09B | |
| Average | 13.50x | 558.67x | 2,641.06x | 0.14% | 23.06B | |
| Weighted average by Cap. | 29.72x | 371.35x | 1,450.53x | 0.24% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- A068270 Stock
- Valuation Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition